C

Cidara Therapeutics
D

CDTX

19.040
USD
-1.64
(-7.93%)
مغلق
حجم التداول
930
الربح لكل سهم
-19
العائد الربحي
-
P/E
-1
حجم السوق
134,167,892
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AZN
    AZN
    -1.830
    (-2.81%)
    66.385 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    754.1 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    101.205 USD
    NVO
    NVO
    -3.620
    (-3.44%)
    104.55 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    103.54 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    26.16 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    462.07 USD
    المزيد
الأخبار

العنوان: Cidara Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak(R) platform targeting oncologic, viral and autoimmune diseases.